AssetMark Inc’s Twist Bioscience TWST Stock Holding History

AssetMark Inc’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.67K	Buy	19 +17	+850%	+$2.1K	﹤0.01%	2854
2026 Q2	$206	Sell	2 -4	-67%	-$260	﹤0.01%	3423
2026 Q1	$285	Hold	6	–	–	﹤0.01%	3276
2025 Q4	$190	Hold	6	–	–	﹤0.01%	3262
2025 Q3	$169	Sell	6 -3	-33%	-$91	﹤0.01%	3087
2025 Q2	$331	Buy	+9	New	+$311	﹤0.01%	2808
2024 Q3	–	Sell	-3	Closed	-$148	–	2362
2024 Q2	$148	Buy	+3	New	+$122	﹤0.01%	2023
2022 Q4	–	Sell	-32	Closed	-$1K	–	1661
2022 Q3	$1K	Hold	32	–	–	﹤0.01%	1487
2022 Q2	$1K	Hold	32	–	–	﹤0.01%	1451
2022 Q1	$2K	Sell	32 -8,799	-100%	-$488K	﹤0.01%	1444
2021 Q4	$683K	Buy	+8,831	New	+$906K	﹤0.01%	489

Other funds holding TWST

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

AssetMark Inc's TWST Position: Q3 2026 in Review

AssetMark Inc increased its Twist Bioscience (TWST) stake by 850% in Q3 2026, buying an estimated $2.1K and bringing the position to 19 shares worth $3.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2854.

AssetMark Inc first reported a position in TWST in Q4 2021 and has held it in 11 quarters since. The position peaked at $683K in Q4 2021. 166 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

AssetMark Inc held 19 shares of Twist Bioscience worth $3.67K as of Q3 2026.
AssetMark Inc bought 17 Twist Bioscience shares in Q3 2026, an estimated $2.1K.
Twist Bioscience made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #2854 holding.
AssetMark Inc first reported a position in Twist Bioscience in Q4 2021 and has held it in 11 quarters since.
AssetMark Inc's Twist Bioscience position peaked at $683K in Q4 2021.
166 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.